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In vitro and ex vivo measurement of the
biophysical properties of blood using
microﬂuidic platforms and animal models†
Yang Jun Kang a and Sang-Joon Lee *b
Haemorheologically impaired microcirculation, such as blood clotting or abnormal blood ﬂow, causes
interrupted blood ﬂows in vascular networks. The biophysical properties of blood, including blood
viscosity, blood viscoelasticity, haematocrit, red blood bell (RBC) aggregation, erythrocyte sedimentation
rate and RBC deformability, have been used to monitor haematological diseases. In this review, we
summarise several techniques for measuring haemorheological properties, such as blood viscosity, RBC
deformability and RBC aggregation, using in vitro microﬂuidic platforms. Several methodologies for the
measurement of haemorheological properties with the assistance of an extracorporeal rat bypass loop
are also presented. We brieﬂy discuss several emerging technologies for continuous, long-term, multiple
measurements of haemorheological properties under in vitro or ex vivo conditions.
1. Introduction
Negative health behaviours (smoking, physical inactivity, poor
diet and inappropriate weight) and factors (cholesterol, blood
pressure and glucose) increase the risk of cardiovascular dis-
eases (CVDs).1 CVDs are the leading cause of death in
advanced countries, and they accounted for 31.5% of all
deaths worldwide in 2013.1 CVDs, including stroke, athero-
sclerosis, coronary heart disease and myocardial infarction,
suddenly occur without any noticeable symptoms and conse-
quently lead to serious complications or unexpected deaths. In
particular, haemorheologically impaired microcirculation
(blood clotting or abnormal blood flow) interrupts blood flows
in vascular networks. Biochemical analyses are used to diag-
nose CVDs by checking several parameters, including bio-
markers, cholesterol, glucose or DNA. However, biochemical
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analyses do not provide suﬃcient diagnostic information on
vascular blockage or blood clotting in advance. Thus, early
detection of CVD remains diﬃcult. On the basis of close
relationships between CVDs and haemorheological properties,
several research groups recently demonstrated that the haemo-
rheological characteristics of blood flows are significantly
correlated with CVDs.2 Lowe et al.3 statistically reviewed the
significant association between biophysical properties of
blood [haematocrit, plasma viscosity, blood viscosity and
erythrocyte sedimentation rate (ESR)] and coronary heart
disease. Yayan4 reported that the specificity and sensitivity of
ESR for coronary heart disease are 70.59% and 67.65%,
respectively. Given that the biophysical properties of blood
(haematocrit, blood viscosity, plasma viscosity, blood visco-
elasticity, RBC aggregation, RBC deformability and ESR)
provide valuable information on haematological disorders or
diseases, they have been recommended for use in monitoring
or diagnosing patients with CVDs.
In 1952, Copley introduced the word ‘haemorheology’ and
defined it as the study of how blood and blood vessels function
and interact as parts of living organs.5 In other words, haemo-
rheology deals with blood flow and deformation of blood cells,
blood compositions and blood vessels. Blood is composed of
cell components [red blood cells (RBCs), white blood cells
(WBCs), and platelets] and plasma. As shown in Fig. 1, haemo-
rheological properties are represented by several factors,
including haematocrit (Hct),6,7 cell components (RBCs, WBCs
and platelets), cell-free layer,8,9 blood vessel diameter10,11 and
plasma proteins. RBCs are strongly related to the biophysical
properties of blood because they constitute approximately 45%
of blood volume. Instead of counting the number of RBCs in a
specific volume, haematocrit, which is defined as the volume
ratio of RBCs to the total volume, has been widely used.
Secondly, the RBC membrane is made up of a lipid bilayer and
has several tiny gates for the transport of ions, molecules and
signals. This membrane behaves like a mechanical structure
under an external force or stimuli. An individual RBC is
elongated and aligned with the shearing blood flow. RBC
membranes exhibit tank-treading or flexible motion.12 The
surface properties of RBC membranes are crucial in blood vis-
cosity determination and RBC aggregation. A high stiﬀness of
RBC membranes leads to increased blood viscosity or
decreased RBC aggregation. Thirdly, plasma proteins are com-
posed of albumin, fibrinogen and immunoglobin. Among
these plasma proteins, fibrinogen, which participates in clot-
ting formation, contributes to RBC aggregation and blood vis-
cosity significantly. Haemorheological properties depend on
the molecular weight and morphological structure of plasma
proteins. In addition, inflammations or tissue injuries contrib-
ute to changes in plasma proteins.13
Microfluidic platforms possess several advantages, includ-
ing small volume consumption, fast response, easy handling
and disposability. Compared with conventional methods, they
present a strong potential for use in point-of-care testing.
Thus, microfluidic platforms have been widely used in haemo-
rheological studies on blood. Blood viscosity can be deter-
mined by several factors, including haematocrit, plasma vis-
cosity, RBC deformability and RBC aggregation. At high shear
rates, blood viscosity is determined by the deformation and
alignment of RBCs in blood flows. At low shear rates, RBC
aggregation contributes to an increase in blood viscosity. In a
microfluidic platform, a blood sample is delivered to a micro-
channel with the aid of a syringe pump. Blood viscosity is
measured under stable flow conditions at shear rates higher
than 10 s−1.14,15 However, at shear rates lower than the said
value, a microfluidic viscometer does not provide consistent
viscosity values because of unstable flow conditions. Unlike
blood viscosity, RBC aggregation is quantified under quasi-
static flow conditions. Specific variations in blood cells or
plasma proteins are rarely employed to measure blood vis-
cosity because blood viscosity can be determined simul-
taneously by several factors. Thus, the measurement of RBC
deformability is fundamentally required for evaluating the
mechanical properties of individual RBCs.
Three representative properties, namely, blood viscosity,
RBC aggregation and RBC deformability, need to be evaluated
independently when monitoring several haemorheological
blood factors. In this review, several measurement techniques
for haemorheological properties (blood viscosity, RBC deform-
ability, and RBC aggregation) are categorised and discussed
based on the working principles of microfluidic platforms (i.e.
in vitro) and the use of animal disease models (i.e. ex vivo).
2. In vitro haemorheological study
using microﬂuidic devices
2.1 Measurement of blood viscosity using a microfluidic device
Blood viscosity is the most important property for characteris-
ing blood samples.16 As a representative biomarker, blood vis-
cosity has been used to monitor haematological diseases eﬀec-
tively. It is also an essential parameter in the evaluation of wall
Fig. 1 Overview of quantitative measurements of haemorheological
properties using microﬂuidic platforms and disease animal models.
Haemorheological properties are determined using several factors,
including haematocrit, white blood cell rheology, platelet activation,
cell-free layer, vessel diameter and plasma proteins. Among them, blood
viscosity, red blood cell (RBC) deformability and RBC aggregation are
mainly used for the early detection of cardiovascular diseases. In this
review, several measurement techniques based on microﬂuidic plat-
forms (i.e. in vitro) or animal disease models (i.e. in vivo or ex vivo) used
for quantifying haemorheological properties are categorised and dis-
cussed based on their working principles.
Critical Review Analyst
2724 | Analyst, 2018, 143, 2723–2749 This journal is © The Royal Society of Chemistry 2018
Pu
bl
ish
ed
 o
n 
11
 A
pr
il 
20
18
. D
ow
nl
oa
de
d 
by
 P
O
ST
EC
H
 L
ib
ra
ry
 o
n 
6/
5/
20
19
 2
:3
1:
57
 A
M
. 
View Article Online
shear stress that acts on vascular endothelial cells.17 Dissolved
gases and nutrients are exchanged through microcirculation
from narrow-sized capillary vessels to peripheral tissues and
vice versa. Blood viscosity decreases at high shear rates due to
the elongation and alignment of RBCs along the flow direction.
RBCs easily pass through narrow-sized capillary vessels because
the high deformability of RBCs reduces hydraulic resistance in
blood vessels. However, blood viscosity increases at low shear
rates due to RBC aggregation, which is significantly enhanced
by several factors, including surface property of the RBC mem-
brane, plasma proteins and haematocrit. Blood behaves as a
shear-thinning fluid because blood viscosity decreases with an
increase in shear rates. Haematocrit also contributes signifi-
cantly to an increase in blood viscosity. Thus, blood viscosity is
measured at a fixed haematocrit. Blood temperature and
plasma proteins are also crucial in the measurement of blood
viscosity. Blood viscosity has been clinically used in the diagno-
sis of haematological disorders or hyper-viscosity syndromes,
including hypertension,18,19 diabetes,20 Alzheimer’s disease,21
stroke,22 coronary artery disease,23 atherosclerosis24,25 and myo-
cardial infarction.26 In this section, several microfluidic-based
platform techniques for evaluating fluid viscosity are reviewed
and summarised in Table 1.
2.1.1 Microfluidic comparator with co-flowing streams.
Quake et al.27 proposed a comparator channel to measure the
pressure drop in a microfluidic nonlinear resistor. The micro-
fluidic device possessed nonlinear and control channels. Both
channels were connected by a comparator channel. After sup-
plying two fluids to the two side channels, the nonlinear
relationship between the flow rate and the pressure drop was
evaluated by monitoring the interface of the two fluids in the
comparator channel. Stone et al.28 proposed a diﬀerential
manometer for measuring dynamic variations in pressure
drop in a microfluidic channel [Fig. 2A-(a)]. The microfluidic
device was composed of twin channels (i.e. test and control)
connected by a comparator channel. The twin channels had
rectangular cross sections (width = 5 µm and depth = 5 µm).
The control fluid that flowed through the control channel was
dyed to visualise the interfacial location of the two fluids in
the comparator channel. A test fluid was prepared by adding
RBCs to a specific solution. Using precise pressure control
units, the test and control fluids were simultaneously supplied
to the test and control channels, respectively. The pressure
drop in the test channel changed the interfacial position
between the two fluids in the comparator channel. Thus, the
pressure drop in the test channel was quantified by monitor-
ing the interfacial location in the comparator channel. The
diﬀerential manometer was demonstrated to be eﬀective in
measuring the pressure drop related to the flow of RBCs, rigi-
dified RBCs and haemolysis in the test channel.
Mugele et al.29 established a unique power-law scaling
relationship between interface displacement and pressure
drop in a microfluidic comparator. The scaling exponent was
increased from 0.51 (for a square channel) to 0.93 (for a wide
Table 1 Summary of microﬂuidic-based techniques for measuring ﬂuid viscosity
Principle Measurement quantity Test fluid Comment Ref.
Co-flowing streams Interfacial location Non-Newtonian (PEO,
CpCl-NaSal)
Image processing 31 and 33
Conductivity measurement
Interfacial location Non-Newtonian (PEO) Image processing 32
Multiple shear rates
Interfacial location Non-Newtonian (PAA,
PEO)
Image processing 35 and 36
Three fluid streams
Flow rate for relocating the interface to
the centre channel
Newtonian (BSA) Flow rate control with a
syringe pump
37
Microfluidic flow
compartment
Number of channels filled with test
fluid in single microfluidic channel
array
Non-Newtonian (Blood) Digital counting 14 and 38
Single microfluidic channel
array
Temperature control
Number of channels filled with test
fluid in 10 microfluidic channel arrays
Non-Newtonian (Blood) Digital counting 39
Multiple shear rates with
10 microfluidic channel arrays
Reversal flow switching
manipulation
Flow rate for inducing reversal flow in
bridge channel
Non-Newtonian (Blood) Flow rate control with a
syringe pump
15
Integrated sensor Pressure drop at constant flow rate
with a syringe pump
Non-Newtonian
(Xanthan, PEO)
Bulk-sized pressure sensor 45, 47, 48 and 49
MEMS pressure sensor
Liquid metal-based sensor
Flow rate at constant pressure drop Newtonian
(Monoclonal antibody)
Bulk-sized flow meter 46
Advancing meniscus Mean velocity Newtonian (Plasma) Image processing 50, 51, 53 and 54
Non-Newtonian (Blood) Glass or PDMS channel
Self-calibration with DI water
Flow rate under pressure control Newtonian (BSA,
Glycerin)
Smartphone-based imaging 55
Flow rate with a hand-held pipette Non-Newtonian (Blood) Smartphone-based imaging 56
Film with scale
Electrical impedance Electric resistance Newtonian (Plasma) Electrical impedance
measurement
57
Non-Newtonian (Blood)
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channel). They integrated the microfluidic comparator into a
T-junction and measured the pressure drop resulting from the
confined movement of droplets in rectangular channels30
[Fig. 2A-(b)]. Using the microfluidic comparator channel, they
investigated the eﬀects of drop size, droplet viscosity and capil-
lary number on hydrodynamic flow resistance.
Colin et al.31 utilised a microfluidic comparator to measure
fluid viscosity. Parallel co-flowing streams in the microfluidic
comparator (width = 200 μm and depth = 100 μm) were used
[Fig. 2A-(c)]. The channel width occupied by each fluid stream
depends on flow rate and fluid viscosity. Thus, the fluid vis-
cosity of a test fluid (unknown viscosity, μT) with respect to the
reference fluid (known viscosity, μR) was measured by monitor-
ing the channel width occupied by each fluid with varying the
flow rate ratio of the reference fluid to the test fluid (i.e.
μT/μR = [WT/WR]·[QR/QT]). The researchers used this micro-
fluidic platform to measure the viscosities of a Newtonian
fluid (oil) and a non-Newtonian fluid (PEO) for a wide range of
shear rates. Compared with a conventional viscometer, the
microfluidic comparator enables the measurement of fluid
viscosity with a measurement accuracy of 20% error. Vanapalli
et al.32 proposed a multiplexed microfluidic comparator for
the simultaneous measurement of fluid viscosity at various
shear rates. The multiplexed microfluidic comparator was
Fig. 2 Microﬂuidic-based viscosity measurement techniques that utilise the principles of a microﬂuidic comparator, a microﬂuidic ﬂow compart-
ment, and reversal ﬂow switching manipulation. (A) A microﬂuidic comparator is used to measure the variations in pressure drop produced by (a) a
single RBC28 and (b) a single moving droplet.30 (c) The ﬂuid viscosity ratio of a test ﬂuid to a reference ﬂuid is quantiﬁed by monitoring the channel
width (WT, WR) occupied by each ﬂuid stream in a single channel.
32 (d) Interface detection by monitoring the conductivity of parallel ﬂows between
conductive and non-conductive ﬂuids.33 (e) Measurement of the ﬂuid viscosity of a non-Newtonian ﬂuid using three ﬂowing streams.36
(f ) Interfacial relocation to the centre line by controlling the ﬂow rate of each ﬂuid.37 (B) Measurement of blood viscosity by monitoring the number
of channels ﬁlled with two ﬂuids in a single microﬂuidic channel array.14 (C) Measurement of blood viscosity using reversal ﬂow switching manipu-
lation in a Wheatstone-bridge channel.15 (a) Flow switching manipulation in the bridge channel with varying ﬂow rates of the reference ﬂuid.
(b) Blood ﬂow in the bridge channel is reversely moved at a speciﬁc ﬂow rate ratio of Qsref/Qtest = 2.37. Reproduced from ref. 14, 15, 28, 30, 32, 33,
36, and 37 with permission from Springer, AIP Publishing, National Academy of Sciences, Royal Society of Chemistry, and WILEY-VCH.
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capable of a reliable and simultaneous measurement of
viscosity curves for Newtonian fluids (glycerol), polymeric solu-
tions (PEO) and consumer products.
Colin et al.33 introduced a new interface detection method
with the aid of conductivity measurement without optical
detection of the interface position in the microfluidic com-
parator [Fig. 2A-(d)]. The upper and lower electrodes were de-
posited on two glass substrates. A microfluidic device was pre-
pared by bonding two glass substrates to both sides of a
polymer-film channel (width = 9 mm and depth = 200 µm).
During experiments, the reference fluid was used as a conduc-
tor, and the test fluid was used as an insulator. The conduc-
tivity measured by electrodes allowed for the detection of the
interfacial location. This technique was applied to measure the
viscosity of a non-Newtonian fluid (PEO) over a wide range of
shear rates. The measured viscosity was in good agreement
with that measured by a conventional rheometer, and the
measurement error was within 15%. To compensate for vari-
ations in fluid viscosity depending on the interfacial location
along the channel width, Kang34 proposed the use of a correc-
tion factor (Fμ) in the viscosity formula of co-flowing streams
in a rectangular channel with a certain aspect ratio (AR =
depth/width) (i.e. μT/μR = Fμ·[WT/WR]·[QR/QT]). Using the inter-
facial location obtained via computation fluid dynamics ana-
lysis, the correction factor was obtained as a function of inter-
facial location in the comparator channel. The viscosities of a
Newtonian fluid (glycerin) and a non-Newtonian fluid [blood
(haematocrit = 30%, 40% and 50%)] were consistently
measured at various interfacial locations. Blood viscosity
remained consistent regardless of the interfacial location. A
quantitative study showed that the proposed method measures
blood viscosity accurately and continuously.
Nguyen et al.35 reported a microfluidic rheometer based on
hydrodynamic focusing with three co-flowing streams. A test
fluid (core stream) was sandwiched between two reference
fluids (sheath flows). The width of the test fluid was varied
depending on the viscosity and flow rate ratios of the test fluid
to the reference fluid. The experimental results obtained for a
Newtonian fluid (DI-water) and a non-Newtonian fluid (PEO)
showed that the measurement range and error can be improved
by adjusting the flow rate ratio between the core and sheath
streams. The researchers also discovered that a microfluidic
channel with a high aspect ratio is highly suitable for test fluids
with a high viscosity ratio of the test fluid to the reference fluid.
Meanwhile, Bausch et al.36 presented a diﬀerential capillary
viscometer to determine the exponent (n) of the power-law
model (i.e. μ = μ0(γ˙)
n−1, where γ˙ is the shear rate) for non-
Newtonian fluids (PAA and WLM) [Fig. 2A-(e)]. Unlike the micro-
fluidic rheometer based on hydrodynamic focusing,35 the refer-
ence fluid flowed between the two test fluids in the comparator
channel. The test fluids in the reference and analyser channels
experienced diﬀerent shear rates in the comparator channel due
to the diﬀerent geometries of the reference (upper stream) and
analyser (lower stream) channels. As a result, the power-law
exponent determined by diﬀerent geometries showed good
agreement with that obtained with a conventional rheometer.
Instead of detecting the interfacial location in the compara-
tor channel, Park et al.37 used another viscosity measurement
technique by adjusting the flow rate ratio to relocate the inter-
face to the middle position of the comparator with a very small
aspect ratio (i.e. AR = 0.047) [Fig. 2A-(f )]. When the interface
was relocated to the middle position, the viscosity ratio of the
test fluid to the reference fluid (μx/μref ) was measured by moni-
toring the flow rate ratio of the test fluid to the reference fluid
(Qref/Qx) (i.e. μx/μref = Qref/Qx). This method was successfully
used to measure variations in the viscosity of a plasma protein
(BSA) under various temperature conditions.
2.1.2 Microfluidic flow compartment with a microfluidic
channel array. Yang et al.14,38 reported a microfluidic visc-
ometer with a microfluidic channel array (MCA) for measuring
blood viscosity. Instead of detecting the interface in the com-
parator channel, the viscosity ratio of the test fluid to the refer-
ence fluid (µspl/µref ) was measured by counting the numbers of
channels filled with each fluid at the same flow rate of both
fluids (i.e. µspl/µref = Nspl/Nref ). The microfluidic device was
composed of two inlets and a spacious diverging channel that
contains multiple identical small channels (number of chan-
nels = 89, width = 50 µm and depth = 60 µm).14 The device was
integrated with micro-scale thermocouples, a Peltier chip and
a temperature controller [Fig. 2B]. Given that the proposed
viscometer can measure viscosity at a single shear rate, vari-
ations in fluid viscosity over a wide range of shear rates were
measured by varying the flow rate of each fluid several times.
Experimental results for a Newtonian fluid (SDS) and a non-
Newtonian fluid (various blood samples) indicated that the
normalised diﬀerence between the proposed method and a
conventional viscometer was less than 5%. By contrast, to
generate multiple shear rate conditions (i.e. 10 diﬀerent shear
rates) at a single flow rate, Yang et al.39 proposed a microflui-
dic viscometer with 10 MCAs (the total number of each micro-
fluidic channel array = 100). Each microfluidic channel array
had diﬀerent channel widths. The proposed method could
measure variations in blood viscosity for at least 10 diﬀerent
shear rates. Compared with the normalised diﬀerence of con-
ventional viscometers, that of the proposed method was
approximately 5.3%.
2.1.3 Manipulation of reversal flow switching in a
Wheatstone-bridge channel. Lee et al.15 measured fluid vis-
cosity by monitoring reversal flow switching in the microflui-
dic analogue of a Wheatstone-bridge circuit. The microfluidic
device was composed of two sets of inlets and outlets, two
identical side channels for guiding two fluids and one bridge
channel connected to the side channels. Flow switching in the
bridge channel was caused by hydrodynamic force balancing
at both junctions of two side channels. When the viscosity of a
test fluid (µtest) is larger than that of the reference fluid (µref )
at the same flow rate (Qtest = Qref ), the test fluid moves in the
right direction in the bridge channel because the pressure at
the left junction is higher than that at the right junction (PL >
PR). To obtain a hydrodynamic balance between both side
channels, the flow rate of the reference fluid was precisely con-
trolled to increase pressure at the right junction. The flow
Analyst Critical Review
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direction of the reference fluid was reversed towards the left
direction at a specific flow rate ratio (QSref /Qtest). Then, the vis-
cosity ratio of the test fluid to the reference fluid was measured
by monitoring the specific flow rate ratio (i.e. µtest/µref = QSref /
Qtest) [Fig. 2C-(a)]. To demonstrate the performance of the pro-
posed method, blood with haematocrit = 50% (test fluid) and
1× PBS (reference fluid) were simultaneously supplied to each
inlet of the microfluidic device by using two syringe pumps. At
a specific flow rate ratio of QSref /Qtest = 2.37, the test fluid rever-
sely flowed from the right direction (i.e. Qtest = Qref ) to the left
direction in the bridge channel. By monitoring the reversal
flow switching in the bridge channel, the viscosity ratio of the
test blood to the reference fluid was quantified as µtest/µref =
2.37 [Fig. 2C-(b)]. The proposed method was then employed to
measure the viscosity of Newtonian fluids (glycerin and oil).
The normalised diﬀerence in viscosity measured by the pro-
posed method was 6.5% less than that obtained by a conven-
tional method. In addition, blood viscosity was successfully
measured for blood samples with diﬀerent haematocrit, RBC
membrane fixation and channel width of both side channels.
This reversal flow switching method was successfully utilised
to evaluate the relationship between velocity profile and blood
viscosity40 and measure the blood viscoelasticity41 and blood
viscosity of blood circulating in a rat bypass loop.42–44
2.1.4 Integrated sensor-based measurement of fluid vis-
cosity. Using the pressure drop measured by a pressure trans-
ducer installed in the microfluidic channel (width = 150 µm
and depth = 150 µm),45 the fluid viscosity at a specific flow
rate has been estimated using the Hagen–Poiseuille equation
(i.e. pressure drop (ΔP) = fluidic resistance [Rf ]·flow rate [Q]).
To evaluate polymer degradation, the viscosity of a PEO solu-
tion as a non-Newtonian fluid was measured at a high shear
rate of 106 s−1.
Migler et al.46 used a micro-capillary viscometer to charac-
terise the kinematic behaviour of protein solutions. The visco-
meter consisted of two pressure chambers connected by a
polyethylene tube via an external flow rate meter. By measur-
ing the flow rate under precise pressure-diﬀerence control, the
viscosity of a test fluid was evaluated via an analytical formula.
The micro-capillary viscometer was used to measure the vis-
cosity of a monoclonal antibody as a function of the shear
rate, protein concentration and temperature.
To measure the pressure drop in a microfluidic channel
using three integrated pressure sensors, McKinley et al.47 uti-
lised a high-shear-rate viscometer to measure the viscosity of
complex fluids at a high shear rate of 80 000 s−1. The micro-
fluidic device was fabricated from Pyrex mounted on a gold-
coated silicon with MEMS-based pressure sensors (width =
800 μm and depth = 800 µm). Similarly, Ayela et al.48 used a
capillary rheometer to measure the viscosity of silicon oil over
a broad range of shear rates. The viscometer was composed of
an anodic bonded silicon–Pyrex derivative microfluidic
channel equipped with local electrodes [Fig. 3A-(a)].
Yang et al.49 used a liquid metal-based pressure sensor
[Fig. 3A-(b)]. The integrated pressure sensor in the microfluidic
device was composed of three polydimethylsiloxane (PDMS)
layers, namely, a microfluidic channel for fluid flow (lower
layer), a thin film (separation layer) and an electrical-resistance
channel (upper channel). The electrical-resistance channel was
filled with Galinstan as a liquid metal. The pressure that devel-
oped in the microfluidic channel decreased the cross-sectional
area of the electrical-resistance channel, which in turn led to
an increase in electrical resistance. The pressure at a specific
position in the microfluidic channel was evaluated by measur-
ing the variations in electric resistance. The variations in elec-
trical resistance were determined for given pressure conditions
by using an analogue circuit that included a Wheatstone-
bridge circuit and an operational amplifier. To use the liquid
metal-based pressure sensor, its calibration curve was obtained
by varying the pressure from 0 kPa to 230 kPa for deionized
water. The viscosity of a test fluid that flowed through a micro-
fluidic channel with a rectangular shape was estimated by
using the Hagen–Poiseuille relation for a specific flow rate.
The proposed method was applied to measure the viscosities
of a Newtonian fluid (SDS) and a non-Newtonian fluid (PEO).
The normalised diﬀerence between the proposed method and
a conventional viscometer was less than 7%.
2.1.5 Advancing meniscus in a single capillary channel.
Burns et al.50,51 used a self-calibrated microfluidic capillary
viscometer to measure fluid viscosity with a capillary force-
driven flow. The capillary viscometer was created by bonding a
glass channel to a silicon substrate. The glass channel was
etched to have a rectangular cross-sectional shape (width =
340 µm, depth = 35 µm) [Fig. 3B-(a)]. When a small drop of
liquid (0.6 µL) was placed at the inlet of the microfluidic
channel, the diﬀerence in the advancing meniscus (R2) and
the receding meniscus (R1) induced a capillary pressure diﬀer-
ence. This capillary pressure diﬀerence made the liquid move
as time elapsed [Fig. 3B-(b)]. An analytical study indicated that
fluid viscosity (µ) can be determined as functions of surface
tension, contact angle and channel geometry. In other words,
prior knowledge of surface tension, contact angle and channel
geometry is required to evaluate fluid viscosity. In addition,
variations in surface tension, contact angle and channel geo-
metry can reduce measurement accuracy. To solve these pro-
blems, a self-calibrated microfluidic viscometer comprising
two identical parallel channels was recommended. The rec-
ommended viscometer could accurately measure the viscosity
of test fluids by eliminating the eﬀects of surface tension,
contact angle and channel geometry on measurement accu-
racy. In a demonstration, the viscosities of biofluids (urine and
blood plasma) as Newtonian fluids were accurately measured
with a 3% error compared with a conventional viscometer.50
The self-calibrating viscometer could also accurately measure
the viscosity of non-Newtonian fluids, including PEO, xanthan
gum and hydrolysed polyacrylamide.51 Furthermore, the vis-
cosity of a test fluid was automatically measured by monitor-
ing the advancing meniscus in the channel through the use of
three droplet sensing techniques, namely, a digital electrode,
an analogue electrode and a thermal electrode.52
To replace expensive silicon-glass devices, Zheng et al.53,54
introduced a PDMS viscometer for monitoring the advancing
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meniscus of a test liquid in a capillary channel. The wettability
of the fluid on the PDMS surface did not aﬀect the viscosity
measurement because the capillary forces were cancelled out
in the data analysis. For various fluids, including Newtonian
fluids (i.e. glycerin, blood plasma and ethanol)53 and non-
Newtonian fluids (i.e. PEO and blood),54 the PDMS-based visc-
ometer measured the fluid viscosity more consistently than
conventional viscometers.
Instead of a capillary pressure-driven flow in the capillary
channel, Vanapalli et al.55 developed a stress-controlled micro-
fluidic viscometer with the aid of a smartphone [Fig. 3B-(c)].
The flow rate of a test fluid was measured by monitoring the
advancing interfacial motion in a glass capillary. Fluid was
continuously supplied to a microfluidic channel (width =
1000 μm and depth = 31 μm) by using a constant pressure
source. A smartphone was utilised to visualize the advancing
meniscus of the fluid in the glass capillary attached to the
outlet of the microfluidic channel. By analysing the interface
movement in the glass capillary from images captured by the
smartphone, the viscosity of the test fluid was determined
using the analytical formula between pressure drop and flow
rate. Unlike previous methods, this approach enables the
measurement of the viscosity of multiple samples in parallel
because all samples can be supplied by a single pressure
source. For a typical demonstration, the proposed method was
used to measure the viscosities of Newtonian fluids (glycerin
and BSA) and a non-Newtonian fluid (PEO). Instead of an
external pressure source, a handheld pipette was used to sim-
ultaneously supply blood and the reference fluid into parallel
capillary channels.56 By using a quantification method similar
Fig. 3 Microﬂuidic-based viscosity measurement techniques that utilise the principles of an integrated sensor, an advancing meniscus and electri-
cal impedance. (A) Measurement of ﬂuid viscosity using an integrated sensor. Under a given ﬂow rate condition, the pressure drop is measured using
(a) a membrane deﬂection-based pressure sensor48 and (b) a liquid-metal-based pressure sensor.49 (B) Measurement of ﬂuid viscosity using an
advancing meniscus in a single capillary channel. (a) A capillary viscometer using a capillary force-driven ﬂow.50 (b) Snapshot showing the advancing
meniscus of a test ﬂuid over time.50 (c) A stress-controlled microﬂuidic viscometer combined with a smartphone.55 (C) Measurement of blood vis-
cosity using electrical impedance spectroscopy.57 (a) Equivalent circuit model of blood ﬂow. (b) Relationship between electric resistance and appar-
ent viscosity. Reproduced from ref. 48–50, 55, and 57 with permission from Springer, AIP Publishing, MDPI AG, American Chemical Society and
Elsevier Science SA.
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to that proposed by Vanapalli et al.,55 the researchers
measured blood viscosity over various shear rates.
2.1.6 Electric impedance-based blood measurement. Zhao
et al.57 examined the rheological properties of blood in a
microfluidic channel. The rheological behaviour of blood was
evaluated by measuring electrical impedance (resistor and
capacitor) via electrical impedance spectroscopy. As illustrated
in Fig. 3C-(a), blood was modelled as a discrete circuit
network. An individual RBC was represented by two capacitors
and one resistor connected in series.58 However, blood plasma
was only modelled as a resistor. Two microelectrodes (width =
500 µm, thickness = 0.5 µm and interspace = 500 µm) were pat-
terned on the bottom surface of the microchannel (width =
500 µm and depth = 500 µm). The electrodes were extended
over the entire width of the microfluidic channels. The electri-
cal impedance of blood flow was measured by sweeping the sti-
mulating frequency in the range of 1 Hz to 100 kHz. The elec-
trical resistance of blood plasma remained constant over a
wide range of shear rates. The electrical resistance varied by
less than 2%. Fig. 3C-(b) shows the relationship between elec-
trical resistance and fluid viscosity. Regression analysis of the
relationship between blood viscosity and electrical resistance
revealed a high correlation coeﬃcient (i.e., R2 = 0.935). Thus,
the electrical impedance-based rheometer has potential for
use in determining the rheological properties of blood
samples.
2.1.7 Discussion on blood viscosity techniques. As sum-
marised in Table 1, several measurement techniques have
been developed to measure the shearing viscosity of various
Newtonian or non-Newtonian fluids. The microfluidic flow
compartment method, the reversal flow switching manipu-
lation method and the co-flowing stream method can
measure the viscosity of various blood specimens over a wide
range of shear rates. First, the microfluidic flow compartment
method can measure blood viscosity by counting the number
of channels filled with blood in a label-free and sensor-less
manner. However, the measurement accuracy of the method
decreases when many channels are filled with blood (i.e. high
viscosity ratio of blood to the reference fluid). In addition,
clogging of cells and bubbles (air or oxygen) hinders the accu-
rate measurement of blood viscosity.59 Two precise syringe
pumps are required to control two fluids at constant flow
rates. Image acquisition with a microscope or a high-speed
camera is also required to count the number of channels
filled with blood.
Second, the reversal flow switching manipulation method
can monitor the reversal of flow direction by varying the flow
rate of the reference fluid using a syringe pump. Measurement
accuracy depends largely on the performance of the syringe
pump. An air compliance unit60 is adopted to consistently
deliver blood and reference fluid at consistent flow rates.
Critical issues, including clogging of cells and the presence of
bubbles, can be minimised using a simple H-shaped channel.
Compared with the microfluidic flow compartment method,
the reversal flow switching manipulation method can evaluate
blood viscosity within a specific duration of time. However,
diﬃculties arise when this method is used to continuously
measure blood viscosity.
The co-flowing stream method can be considered a promis-
ing alternative for measuring blood viscosity in a continuous
and label-free manner. Given that this method adopts a wide
rectangular channel with a very small aspect ratio, critical
issues, including clogging of cells and the presence of
bubbles, can be resolved. Furthermore, when two syringe
pumps are removed using a hand-held pipette56 or an air-com-
pressed syringe,61 the method might present a high potential
for use in clinical settings. If the co-flowing stream method
includes a correction factor (i.e. a modified parallel flow
method),62 blood viscosity could be measured reliably and con-
tinuously under ex vivo conditions.
2.2 Measurement of RBC deformability using a microfluidic
device
Given that the characteristic length scale of a microfluidic
channel is similar to that of cells, a microfluidic device is
considered a promising platform for probing mechanical bio-
markers.63 Compared with conventional biochemical bio-
markers, the mechanical biomarkers in a microfluidic
device possess several advantages, including being label-free,
high throughput and potential cost-eﬀectiveness. Various
approaches, including micropipette aspiration, cell transit
analysis, optical stretching and atomic force microscopy, have
been recommended to measure the mechanical properties
(i.e. viscoelasticity, Young’s modulus and viscosity) of individ-
ual cells.64 Blood viscosity significantly varies depending on
several factors, including haematocrit, plasma proteins, RBC
deformability and RBC aggregation. Therefore, changes in
individual RBCs are not eﬀectively detected by measuring
blood viscosity. RBC deformability has recently elicited con-
siderable attention as an eﬀective means of evaluating vari-
ations in individual RBCs. RBC deformability is determined
by several factors, such as membrane cytoskeleton, membrane
integral proteins, cytoplasmic viscosity and the ratio of
surface area to volume.65 Given their high deformability,
normal RBCs easily pass through a narrow-sized capillary.
However, the membrane flexibility of each RBC is reduced
because of cytoskeleton disorders, invasion of cancer cells
and activation of antigens.64 A slight decrease in RBC deform-
ability results in increased blood viscosity and fluidic resis-
tance in the microvasculature. Thus, RBC deformability can
be utilised as a promising biomarker for detecting various
haematological disorders, including malaria, sepsis, diabetes
and sickle cell anaemia. In addition, it has a high potential
for detecting biological heterogeneity and inherent variations
in cell populations. This section focuses on several tech-
niques that can characterise RBC deformability by using
microfluidic platforms. Several methods for measuring RBC
deformability using microfluidic platforms are summarised
in Table 2.
2.2.1 Cell blockage in microfluidic channels. To character-
ise the dynamic behaviours of individual cells, a microfluidic
device was used in a previous study to examine multicellular
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capillary blockages.66 Fig. 4A-(a) shows the microfluidic
channel with a constricted segment. Normal RBCs passed
through a 2 µm constriction. However, malaria-infected RBCs
(i.e. schizont form) were blocked by a 6 µm constriction. This
result implies that a microfluidic device can be used as an
analytical tool to investigate the dynamic behaviours of RBCs
under capillary-flow conditions.
As illustrated in Fig. 4A-(b), RBCs with impaired deform-
ability were blocked in capillaries. Wang et al.67 used a discrete
circuit model to analyse variations in physical properties in
capillaries caused by the clogging of RBCs. Experimental dem-
onstrations and theoretical analysis demonstrated that the
microfluidic capillary network can eﬀectively measure RBC
deformability.
Rathod et al.68 suggested the concept of minimum cylinder
diameter (MCD) for determining the filterability of individual
RBCs in microfluidic channels. As shown in Fig. 4A-(c), indi-
vidual RBCs were trapped in wedge-shaped microfluidic chan-
nels. Then, MCD was calculated from the surface area and
volume of RBCs trapped in the channels. The histogram of
MCD measurement data indicated a distinctive diﬀerence
between malaria-infected RBCs (i.e. MCD = 3.26 ± 0.32 µm)
and normal RBCs (i.e. MCD = 2.64 ± 0.17 µm). The result
showed that the MCD calculated from the surface area and
volume of the RBCs trapped in the microfluidic channels can
be eﬀectively used to distinguish malaria-infected RBCs.
Theodoly et al.69 presented a microfluidic gradual filter for
separating cells by using cell deformability. As shown in
Fig. 4A-(d), the microfluidic filter was composed of two
diﬀerent heights (i.e. blue for 14 µm and red for 4 µm). The
cross section of the filter channel was along the flow direction.
When cells entered the gradual filter, the red-labelled rigid
cells and green-labelled normal cells were distinctively separ-
ated. The cells trapped in the gradual filter were clearly separ-
ated by cell stiﬀness (or deformability) at a low throughput of
100 cells per injection.
2.2.2 Cell aspiration in microfluidic channels. Yue et al.70
proposed the use of instantaneous Young’s modulus
(Einstantaneous) for characterising single cells in suspension. As
shown in Fig. 4B-(a), a single cell was aspirated continuously
in a straight constriction channel, and the cellular entry
process was monitored with a high-speed camera. Microscopic
images showed the cellular entry process into the constriction
channel, including (stage I) instantaneous jumping into the
channel that can be quantified by instantaneous aspiration
length (Linstantaneous), (stage II) a gradual increase in aspiration
length and (stage III) transitional position represented by tran-
sitional aspiration length (Ltransitional). Numerical analysis
showed that the aspiration lengths (Linstantaneous and
Ltransitional) were reversely proportional to instantaneous
Young’s modulus. Using this method, the Einstantaneous of two
lung tumour cells, A549 and 95C, was measured. As depicted
Table 2 Summary of microﬂuidic-based techniques for measuring RBC deformability
Principle Measurement quantity Test cell Comment Ref.
Cell blockage Minimum cylinder diameter (MCD) Malaria-infected RBCs Tapered channel 68
Single cell
Low throughput
Clogging Malaria-infected RBCs Single channel 66
Hardened RBCs Capillary network 67
Monocytic THP-1 Gradual filters 69
Low throughput
Cell aspiration Young’s modulus (aspiration length) Lung tumours (A549,
95C)
Straight channel 70
Cortical tension Malaria-infected RBCs Funnel-shaped channel 71
Cell transit Deformability index RBC, WBC Hyperbolic converging channel 73
Cell margination Malaria-infected RBCs Single channel 74
Transit time RBC, neutrophil Parallel capillary network 75
HL60 myeloid leukemia
Entry time, flow speed and cell
deformation
K562 leukemia Parallel micro-sized constriction 76 and 77
RBC velocity Hardened RBCs Capillary network 79
RBC velocity Malaria-infected RBCs Triangular-shaped pillar channels 78
Cell lysis Hardened RBCs Four filters with diﬀerent orifice
lengths
80
Deformability-based sorting Malaria-infected RBCs Microfluidic with tapered channels 55 and 81
RBC, WBC, CTC High throughput
Blood velocity Malaria-infected RBCs Multiple micro pillars 62, 65 and
83Image intensity Hardened RBCs High throughput
Constant or pulsatile blood flow
Optical stretcher Cell elongation Malaria-infected RBCs Strain model with 84
Kelvin-Voigt model
Low throughput
Electric
impedance
Transit time RBC, WBC Single cell 86
Impedance (magnitude, phase)
Impedance (magnitude, phase) Malaria-infected RBCs Single cell 85
Low throughput
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in Fig. 4B-(b), the value of Einstantaneous was 3.48 ± 0.86 kPa for
A549 cells (n = 199) and 2.99 ± 0.38 kPa for 95C cells (n = 164).
The Einstantaneous values of A549 and 95C showed significant
diﬀerences (i.e. P < 0.01). This result showed that instan-
taneous Young’s modulus can be used to characterise the bio-
physical properties of individual cells.
Ma et al.71 used cortical tension to detect malaria-infected
RBCs. The microfluidic device was composed of two layers,
namely, a fluidic channel with multiple funnel-shaped con-
strictions72 and a pressure attenuator. They also used the
asymmetric ratchet structure to study the directional mobility
of cells.72 Using a geometric model of RBC squeezed through
the funnel constriction as depicted in the inset of Fig. 4C-(a),
the relationship between pressure diﬀerence (ΔP = P3 − P1)
and cortical tension (Tc) was analytically derived as ΔP =
Tc(1/Ra1 − 1/Rb2). Ra1 was equal to W0/2. Rb1 can be calculated
based on mass conservation between the undeformed normal
cell and the squeezed cell in the funnel channel. As shown in
Fig. 4C-(b), the cortical tension at each stage of the parasitized
cell was evaluated as 3.22 ± 0.64 pN µm−1 (uninfected), 4.66 ±
1.15 pN µm−1 (ring stage), 8.26 ± 2.84 pN µm−1 (early-tropho-
zoite stage), 21.38 ± 5.81 pN µm−1 (mid-late trophozoite stage)
and 607 pN µm−1 (schizont stage). The malaria-infected RBCs
from ring stage to schizont stage were 1.5 to 200 times stiﬀer
than uninfected normal RBCs. Thus, the cortical tension of
individual RBCs can be eﬀectively used to detect each infec-
tion stage of malaria-infected RBCs.
2.2.3 Cell transition in microfluidic channels. Lima et al.73
proposed an integrative microfluidic device for simul-
taneously separating the RBCs and WBCs of blood samples
and for assessing their deformability indices. By streaming
WBCs or RBCs through a converging hyperbolic channel
with sudden expansion, the major-axis (Lmajor) and minor-
axis (Lminor) lengths of each cell were measured to determine
the deformability index (DI), namely, DI = (Lmajor − Lminor)/
(Lmajor + Lminor). As illustrated in Fig. 5A, both cells (n = 169)
Fig. 4 Measurement of RBC deformability using clogging, instantaneous Young’s modulus, and cortical tension. (A) Cell blockage in capillary chan-
nels: (a) clogging in a single-constriction capillary,66 (b) clogging in capillary networks,67 (c) the minimum cylinder diameter of cells trapped in taper
channels68 and (d) clogging in gradual ﬁlters with variable pore sizes.69 (B) Instantaneous Young’s modulus (Einstantaneous) estimated using transitional
aspiration length in the constriction channel.70 (a) Cell entry process into a constriction channel. (b) Quantiﬁcation of Einstantaneous for A549 cells (n =
199) and 95C cells (n = 164). (C) Variation in cortical tension for uninfected and malaria-infected RBCs.71 (a) Cortical tension is analytically deter-
mined from deformed RBCs in a funnel-shaped constriction. (b) Variations of cortical tension with respect to each stage of the parasitized cell.
Reproduced from ref. 66–70, and 71 with permission from the National Academy of Sciences, Springer, WILEY-Blackwell, Royal Society of
Chemistry, and Elsevier Science SA.
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had the maximum value of DI (DImax) at the axial position
of 100 µm in the converging channel (i.e. DImax = 0.10
for WBCs and DImax = 0.44 for RBCs), where the average
shear rate had the maximum value of 1761.6 s−1. In addition,
the deformability of RBCs was much higher than that of
WBCs. Thus, the proposed method can be used to simul-
taneously separate blood cells and assess the deformability of
individual cells.
Lim et al.74 used deformation-based cell margination for
separating malaria-infected RBCs from blood samples. The
randomly distributed malaria-infected RBCs (iRBCs) at the
inlet channel move towards the sidewalls as blood passes
through a long straight microfluidic channel (width = 15 µm,
depth = 10 µm and length = 30 mm). For a demonstration,
blood infected with ring and late trophozoite–schizont iRBCs
(haematocrit = 40%) was supplied to the inlet channel at a
flow rate of 5 µL min−1. The separation performance of the
device was evaluated by conducting flow cytometry analysis at
the outlet channels. The experimental results indicated a high
filtration eﬃciency of 92% for late trophozoite–schizont iRBCs
and 75% for early ring iRBCs. Thus, cell margination can be
used to separate iRBCs based on the deformability of individ-
ual RBCs.
To enhance the throughput of the flow cytometry tech-
nique, Fletcher et al.75 utilised single-cell transit time elapsed
for passing through capillary networks. As shown in the inset
of Fig. 5B-(a), the flow cytometry device was trifurcated into
two wide bypass channels and a network of bifurcating chan-
nels split into 64 parallel capillaries (width = 5.89 µm, depth =
13.3 µm and length = 130 µm). To characterise biophysical pro-
perties at diﬀerent disease states, variations in single-cell
transit times were measured using flow cytometry for blood
cells collected from an acute myeloid leukaemia (AML) patient
with leukostasis symptoms (AML2), an AML patient without
leukostasis symptoms (AML1) and two ALL patients without
leukostasis symptoms (ALL1 and ALL2). Neutrophils and RBCs
were also collected from a healthy volunteer. As illustrated in
Fig. 5B-(a), the cell transit time and occlusion were signifi-
Fig. 5 Measurement of RBC deformability using the deformability index, transit time and velocity of individual RBCs. (A) Variations in the deform-
ability index of RBC and WBC ﬂowing along the axial position in a hyperbolic converging microchannel.73 (B) Transit time of individual RBCs passing
through a capillary network. (a) Variation in single-cell transit time and occlusion at diﬀerent disease states.75 (b) Measurement of cell ﬂuidity (β) and
stiﬀness (E) for quantifying the mechanical properties of cells in suspension: the microﬂuidic device (top), inverse relationship between stiﬀness (E)
and power-law exponent (β) (lower left) and distribution of β for cell deformability (lower right).76 (C) Velocity measurement of individual RBCs for
detecting (a) malaria-infected RBCs78 and (b) impaired deformability of RBCs.79 Reproduced from ref. 73, 75, 76, 78, and 79 with permission from
Springer, Royal Society of Chemistry, and Cell Press.
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cantly increased for disease states compared with those in the
control case. The transit time was significantly reduced by
administrating drugs for the cells collected from patients with
leukostasis symptoms. Thus, the transit time of single cells
can be used to assess the biophysical properties of blood cells
with the benefit of high throughput.
Fabry et al.76,77 suggested the concept of cell fluidity (β) for
quantifying the mechanical properties of cells in suspension.
As shown in Fig. 5B-(b), the microfluidic device was composed
of inlet, debris filter and eight parallel constrictions (width =
5 µm and depth = 9 µm) surrounded by a bypass and an
outlet. By measuring the driving pressure (ΔP), maximum
shear strain (εmax) and entry time (tentry) of cells in the micro-
fluidic constrictions, the cell stiﬀness (E) and power-law expo-
nent (β) were estimated via the power-law relationship of tentry =
(εmaxE/ΔP)1/β. The experimental results for K562 leukaemia
cells showed an inverse relationship between cell stiﬀness (E)
and the power-law exponent (β). Given that the power-law expo-
nent (β) represents cell fluidity, it was only used to compare
the mechanical properties of individual cells for control, cells
treated with cytochalasin D and cells treated with glutaralde-
hyde solution. As a result, β had significantly diﬀerent values
(β = 0.31 ± 0.12 for control, β = 0.45 ± 0.15 for cytochalasin D
and β = 0.17 ± 0.04 for glutaraldehyde).76 Furthermore, to
examine the mechanical response of cells to protein expression
levels,77 the researchers simultaneously measured the mechan-
ical properties (E and β) and fluorescence signals of individual
cells by using protein lamin A. Cell stiﬀness (E) was increased
and cell fluidity was decreased as the level of lamin A
increased. Therefore, the suggested method can be used for
quantitative high-throughput measurement (i.e. 10 000 cells
per hour) of cell mechanical properties with a microfluidic
device.
Han et al.78 employed a cell velocity-based cytometer to
detect malaria-infected RBCs in a microfluidic device with
periodically spaced and triangle-shaped pillars (entrance space =
3 µm and depth = 10 µm). As shown in Fig. 5C-(a), the micro-
fluidic device was composed of 10 pillars laterally and 200
pillars longitudinally. Microscopic images indicated diﬀer-
ences in cell velocities for ring stage P. falciparum-infected
RBCs (red arrow) and normal RBCs (blue arrow). After 8.3 s,
the moving velocity of normal RBCs was two times faster than
that of malaria-infected RBCs. The proposed method was able
to analyse the deformability of approximately 10 000 RBCs
before significant clogging occurred in the microfluidic device.
Bitensky et al.79 used RBC velocity for the direct measure-
ment of the impaired deformability of RBCs in microvascular
networks. As shown in Fig. 5C-(b), the microfluidic network
was composed of 34 microchannels (width = 6–70 µm and
depth = 6 µm). The experimental results indicated that RBC
velocity was significantly decreased by the increase in the con-
centration of glutaraldehyde solution from 0% (control) to
0.08%. Network perfusion depended on RBC deformability
and had high sensitivity to small variations in deformability.
Cho et al.80 used the cell lysis rate as a function of the areal
strain (εA) of a cell membrane to monitor the deformability of
individual RBCs. As shown in Fig. 6A-(a), the microfluidic
device comprised four filters with diﬀerent orifice lengths
(width = 2 µm, depth = 2.2 µm and length = 2–16 µm) con-
nected in series along the microfluidic channel. An electric
circuit was integrated to digitally count the number of individ-
ual RBCs passing through the four filters. Using normal RBCs
and chemically hardened RBCs with 0.5 mM azodicarboxylic
acid, accumulated lysis rates were measured with varying
orifice lengths. As shown in Fig. 6A-(b), a significant diﬀerence
in lysis rate was found at the orifice length (L) (i.e. L = 4.3 and
6.7 µm). The experimental results showed that εA = 0.15 was
eﬀective in discriminating deformability diﬀerences between
normal and hardened RBCs. In addition, the deformability of
individual RBCs can be monitored at a rate of 400 cells per
minute.
To eﬀectively diagnose malaria-infected RBCs, Ma et al.81
proposed a simple method for sorting RBCs based on deform-
ability and enriching the concentration of ring-stage
P. falciparum-infected RBCs. As shown in Fig. 6B-(a), deform-
ability-based sorting of RBCs was conducted by using oscil-
latory flow around asymmetric ratchet constrictions (width =
1.5 to 7.5 µm and depth = 4.5 µm). As shown in Fig. 6B-(b),
hardened RBCs exposed to 0% to 0.01% glutaraldehyde solu-
tion were collected from outlets 1 to 3. Cell distribution
shifted rightwards with the increase in the concentration of
the glutaraldehyde solution from 0.015% to 0.05%. To investi-
gate the enrichment of ring-stage malaria-infected RBCs with
low parasitemia, the researchers prepared and collected blood
samples with parasitemia ranging from 0.0004% to 0.04%
from outlets 4 to 7. As shown in Fig. 6B-(c), samples with a
starting parasitemia level order that was lower than the detec-
tion limits of microscopy were enriched to a detectable range.
Furthermore, the proposed method was applied to detect cir-
culating tumour cancer cells,82 and the method captured
>90% of cancer cells from unprocessed whole blood with 104-
fold enrichment of target cells.
Lee et al.83 evaluated RBC deformability by measuring
blood velocity and the image intensity of blood flow in a
microfluidic channel array (N = 105, minimum gap = 2 µm and
depth = 10 µm), as shown in Fig. 6C-(a). To eﬀectively detect
the diﬀerence in the subpopulation of RBCs, the air compli-
ance eﬀect was considered by adding a cavity of approximately
0.3 mL over 0.2 mL blood (haematocrit = 50%) in a disposable
syringe (1 mL). Based on the transient behaviour of blood
flows, RBC deformability was estimated by using three para-
meters [minimum value of blood velocity (〈U〉min), blood
volume (ΔV) and clogging index (C.I.)]. The proposed method
was applied to measure the RBC deformability of homo-
geneous blood, heterogeneous blood and malaria-infected
RBCs. As a result, the three selected parameters were signifi-
cantly varied depending on the degree of deformability.
Deformability measurement of blood samples (0.2 mL, 50%
haematocrit) was completed within 10 min. Furthermore, to
monitor variations in haemodynamic factors, the deformabil-
ity and viscosity65 (or viscoelasticity62) of blood samples were
evaluated by quantitatively visualising blood flows in a micro-
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fluidic device. The microfluidic device was designed by
mimicking a Wheatstone-bridge electric circuit.62 To measure
RBC deformability accurately, the deformability assessment
chamber (DAC) installed at the left lower-side channel had par-
allel micro pillars (N = 43, gap = 2 µm, depth = 4 µm, length =
50–250 µm), as shown in Fig. 6C-(b). After supplying blood
(haematocrit = 50%) and 1× PBS solution to each inlet, blood
volume as a deformability index was evaluated by integrating
the average blood velocity for a certain period. Blood velocity65
or viscoelasticity62 was measured by monitoring the blood-
filled width in the right lower-side channel. The blood volume
was significantly decreased as parasitemia increased. When
parasitemia was greater than 0.515% for the ring stage,
0.0544% for the trophozoite stage and 0.0054% for the schi-
zont stage, blood velocity exhibited an unstable behaviour due
to the cytoadherence of malaria-infected RBCs to the inner
surface of the microchannel.
2.2.4 Optical stretcher-based measurement of RBC deform-
ability. Kaminski et al.84 suggested a microfluidic optical cell
stretcher for measuring the elasticity of malaria-infected RBCs.
Fig. 7A shows a schematic of the optical stretcher, the oper-
ational sequence of the experiment and the deformation beha-
viours of control and trophozoite stage-infected RBCs. As
shown in Fig. 7A-(a), two light-delivering opposing fibers were
supported and aligned by a cross-shaped photolithographic
pattern on the glass slide. The superposed light created a
stable trap. As shown in Fig. 7A-(b), RBCs were trapped and
stretched depending on the light intensity. Fig. 7A-(c) and (d)
showed typical cell edges in trapped and stretched states. The
cell elongation (i.e., the normalized major axis) was then
Fig. 6 Microﬂuidic-based measurement of RBC deformability using strain-dependent cell-lysis rate, deformability-based sorting, and hemodynamic
variation. (A) Measurement of strain-dependent cell-lysis rate.80 (a) Schematic of a microﬂuidic device. (b) Accumulated lysis rate of normal and
chemically-treated RBCs with respect to oriﬁce length. (B) Deformability-based sorting in a ratchet-sorting device.81 (a) Sorting of cells using a taper
funnel constriction. (b) Normalized distribution across the outlets of RBCs treated with various concentrations of GA. (c) Enrichment of malaria-
infected RBCs with parasitemia level from 0.0004% to 0.04%. (C) Variations in hemodynamic parameters of blood ﬂows in parallel micro-pillars. (a)
Temporal variations in the velocity and image intensity of blood ﬂow in the micro-pillars of a symmetric zigzag shape.83 (b) Variations in blood vel-
ocity in DAC and blood-ﬁlled width in a single right-side channel.65 Reproduced from ref. 65, 80, 81, and 83 with permission from the American
Chemical Society, IEEE-Inst Electrical Electronics Engineers Inc., and Royal Society of Chemistry.
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measured by conducting ellipse fitting on cell edge pixels
along the axis of the optical fibers. Fig. 7A-(e) showed temporal
variations of the normalized major axis with respect to con-
trols, cohorts, and malaria-infected RBCs. Cohorts (squares,
n = 32) and controls (triangles, n = 46) exhibited very similar
compliance. But the compliance of malaria-infected RBCs
(circle, n = 24) was greatly reduced compared with the control.
According to the Kelvin–Voigt model, which assumes that vis-
cosity (μ) and elasticity (E) are connected in series for each cell,
the strain [ε(t )] under constant stress (σ) can be described as
ε(t ) = a[1 − exp(−λt )]. Here, λ = E·µ−1 represents the character-
istic deformation rate. a = σ·E−1 denotes the relative amplitude
of the stretch. Both parameters (a and λ) were obtained by con-
ducting a curve-fitting procedure from cell elongation infor-
mation measured by using an optical fibre. The values of a
and λ in the malaria-infected RBCs decreased by a factor of 2
to 3 compared with those in the normal RBCs. Both para-
meters (a, λ) were significantly varied due to the existence of
malaria parasites in RBCs. Given that the technique was
implemented in a non-contact manner, the results were free
from artefacts induced by physical contact required in other
single-cell measurement techniques.
2.2.5 Electrical impedance-based measurement of RBC
deformability. Chandrakasan et al.85 used electric impedance
(EI) micro-flow cytometry to characterise the disease state of
single cells. The platform provided a label-free and non-inva-
sive cell-counting assay with sensing electric impedance. As
shown in Fig. 7B-(a), the microfluidic device was composed of
a constriction channel (width = 30 µm and depth = 5 µm) and
two electrodes (interspace = 20 µm, width = 20 µm and depth =
0.1 µm). To check the pathological states of individual cells, a
dimensionless oﬀset parameter (δ) was obtained by a linear
combination of phase and magnitude changes in electric
impedance. The experimental result indicated that the pro-
posed method can eﬀectively diﬀerentiate malaria-infected
RBCs from normal RBCs.
To achieve a high throughput in biophysical measurements
of RBCs (i.e. 100 cells per 1 s to 150 cells per 1 s), Sun et al.86
used multiple parameters, including mechanical properties
(transit time) and electrical signals (impedance amplitude
ratio and impedance phase increase). As shown in Fig. 7B-(b),
electrical impedance was measured as RBCs flowed through a
straight constriction channel (width = 5 µm and depth =
3 µm). The histograms obtained from the multiple parameters
Fig. 7 Microﬂuidic-based measurement of RBC deformability using optical stretching and electrical impedance. (A) Measurement of cell elongation
using an optical stretcher.84 (a) Schematic of the optical stretcher. (b) Sequence of operation. (c) Normal RBCs trapped at low light intensity. (d)
Normal RBCs elongated at high light intensity. (e) Deformation comparison between normal RBCs and malaria-infected RBCs. (B) Variation in electric
impedance of individual RBCs ﬂowing in a straight constriction channel. (a) Experiment setup for the measurement of the electrical impedance of
single RBCs using a microﬂuidic channel.85 (b) Simultaneous measurement of electrical impedance and transit time of individual RBCs in the con-
striction channel.86 Reproduced from ref. 84, 85, and 86 with permission from the Royal Society of Chemistry and SPIE-Soc Photo-Optical
Instrumentation Engineers.
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for adult and neonatal RBCs showed distinctively diﬀerent bio-
physical properties.
2.2.6 Discussion on RBC deformability measurements. As
summarised in Table 2, several measurement techniques,
including cell blockage, cell aspiration, cell transit, optical
stretcher and electrical impedance, have been developed to
measure the deformability of individual RBCs using micro-
fluidic devices. Clinical applications require the detection of a
large number of RBCs for high-throughput analysis.87 In
addition, establishing a standard protocol for each measure-
ment is essential because several factors, such as storage time,
temperature and osmotic pressure, aﬀect RBC deformability.
Among the several techniques used for RBC deformability, the
cell transit-based technique might have a strong potential for
use in high-throughput screening. By injecting individual
RBCs into a microfluidic device with funnels or micropillars,
RBC deformability was evaluated at a high throughput (i.e. 105
RBCs per 200 s) in a previous study.65 However, because this
method utilises a high-speed camera and digital image proces-
sing, it presents a technical bottleneck when applied in clini-
cal settings. Thus, instead of the imaging-based analysis tech-
nique, the analytical sensor-based technique could be alterna-
tively adopted for clinical applications. It could be employed to
eﬀectively monitor pathological changes in blood circulating
under ex vivo conditions.
2.3 RBC aggregation measurement using microfluidic
devices
RBCs suspended in plasma aggregate and form rouleaux at
stasis or under low shear rates. The aggregated RBCs are dis-
persed at high shear rates. Thus, RBC aggregation is signifi-
cantly varied by (i) intrinsic cellular properties (membrane
deformability and surface charge density), (ii) suspending
medium properties (fibrinogen concentration in plasma and
aggregation-induced macromolecules) and (iii) shear rate of
blood flow in RBCs.88 RBC aggregation has been explained
using cross-bridge89 and depletion-induced90,91 models. The
depletion-mediated model is favoured over the cross-bridge
model for understanding the interactions of RBCs.89 RBC
aggregation is considered the determining parameter of
haemorheological properties and exerts a direct influence on
blood viscosity and microcirculation at low shear rates.
Clinically, RBC aggregation is enhanced in various pathologi-
cal diseases, including malaria, diabetes, hypertension, sepsis
and microcirculatory disorders.
To quantify the RBC aggregation of blood samples in a
microfluidic platform, blood is supplied to a microfluidic
channel. Thereafter, to induce the aggregation or disaggrega-
tion of RBCs, blood flow is agitated or stopped by using exter-
nal devices, such as a syringe pump,34,92 a vacuum pump,93,94
a stirring system,95,96 a vibration system97 and a pinch
valve.61,88 A typical syllectogram is obtained as a function of
time by quantifying blood flows through several methods,
including the measurement of photometric intensity (light
transmission and light backscattering) and electrical impe-
dance and capturing of microscopic or speckle images. As
shown in Fig. 8A-(b), a typical aggregation index (AI) is evalu-
ated with the ratio of the area under the curve (SA) to the total
area of the curve (SA + SB) [i.e., AI = SA/(SA + SB)].
98 This section
focuses on several measurement techniques for characterising
RBC aggregation using microfluidic platforms. The techniques
are summarized in Table 3.
2.3.1 Photometric intensity-based measurement of RBC
aggregation. Shin et al.93,94 proposed a microfluidic aggrego-
meter for measuring RBC aggregation in a microfluidic
channel. As shown in Fig. 8A-(a), the aggregometer was com-
posed of a microfluidic device (width = 4 mm, depth = 200 µm
and length = 40 mm), a laser as a light source, a photodiode
for measuring light reflection, a pressure sensor and a vacuum
pump. After dropping 0.5 mL of a blood sample into a sample
chamber, the microfluidic channel was filled with blood by
operating the vacuum pump. The RBCs were aggregated or dis-
persed depending on the flow rate. By measuring the light
intensity reflected from the blood sample with a photodiode,
the RBC aggregation index was calculated by analysing tem-
poral variations in backscattered light intensity. Fibrinogen in
plasma was found to increase RBC aggregation. It also
increased critical shear stress by about 46% compared with
RBCs suspended in PBS solution. The proposed method was
applied to examine the eﬀect of temperature on RBC aggrega-
tion.94 Threshold shear stress was introduced to monitor the
eﬀect of temperature on the RBC aggregation because the RBC
aggregation index did not fully reflect the trends of RBC aggre-
gation with respect to temperature. The threshold shear stress
and blood viscosity exhibited similar trends with respect to
fluid temperature. Furthermore, the microfluidic device was
used to compare the performance of light-transmission and
back-scattering methods.95 Although both methods had a
good relationship, they produced diﬀerent values of the RBC
aggregation index. However, when an orthogonal polarization
technique was applied, both methods resulted in the same
RBC aggregation index for various blood samples mixed with
diﬀerent concentrations of dextran solution.
ESR is a simple clinical index for screening several inflam-
matory diseases. To investigate the relationship between RBC
aggregation and ESR, Elbuken et al.88 developed a microfluidic
opto-electro-mechanical system.88 As shown in Fig. 8A-(b), the
microfluidic system was composed of a solenoid pinch valve
for disaggregating RBCs in whole blood, a photodetector for
detecting light intensity transmitted from a light-emitting
diode (LED), a microfluidic cartridge and an optical micro-
scope equipped with a camera. The microfluidic cartridge had
a deep channel (width = 1 mm and depth = 1 mm) for ESR and
a shallow channel (width = 44.5 mm and depth = 150 µm) for
RBC aggregation. A solenoid pinch valve was employed to
provide back-and-forth blood flow continuously in the car-
tridge for 15 s. The principle of this measurement system was
based on the analysis of optical light transmitted through
blood samples. An infrared light-emitted diode (LED) of
830 nm in wavelength was placed at the top surface of the car-
tridge, and illuminated the blood-filled channel. The light
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passing through the channel was collected on the photo-
detector located at the bottom of the cartridge. After supplying
the blood sample into the cartridge, the test was started by
fully disaggregating RBCs for 15 s with the aid of a pinch
valve. By turning oﬀ the pinch valve, RBCs were aggregated
immediately. During the aggregation process, the blood
sample was illuminated with the LED. Using a photodetector,
the transmitted light intensity was consecutively recorded for
120 s. It was employed to calculate the aggregation index.
Linear regression analysis showed that the conventional RBC
aggregation index did not provide significant relationship
information on conventional Westergren ESR. To obtain a
suﬃcient relationship between microfluidic ESR and
Westergren ESR, a microfluidic ESR index was proposed to
examine amplitude variations in light intensity (ΔI) at an
elapsed time of t = 120 s [i.e., ΔI = I(t = 120 s) − I(t = 0)]. I(t =
120 s) and I(t = 0) denote the light intensity at t = 120 s and t =
0, respectively. The proposed method quantified RBC aggrega-
tion by analysing the transmitted light intensity obtained from
the shallow channel of the microfluidic cartridge.
2.3.2 Electrical conductivity-based measurement of RBC
aggregation. Temporal variations in blood conductivity can be
used to estimate RBC aggregation. Antonova et al.99 presented
a Couette viscometric system composed of a rotational visc-
ometer and a conductivity measurement device. Given that the
electrical properties of blood in a simple shear flow were
varied depending on the frequency and shear rate,100 conduc-
tivity signals of 2 kHz were recorded under the condition of a
transient shear rate ranging from 0.94 s−1 to 94.5 s−1. Blood
conductivity varied depending on several factors, including the
shear rate, haematocrit, and temperature. As shown in Fig. 8B-
(a), during RBC aggregation, blood conductivity was largely
Fig. 8 Microﬂuidic-based measurement of RBC aggregation by analysing photometric intensity and blood conductivity. (A) RBC aggregation
measurement from the photometric intensity. (a) Microﬂuidic aggregometer including a vacuum pump, a pressure sensor, a microﬂuidic channel
and a laser-photodetector.94 (b) The microﬂuidic system used for the measurement of the erythrocyte sedimentation rate (ESR) and erythrocyte
aggregation.88 (B) The measurement system used for blood conductivity. (a) Variations of blood conductivity with respect to shear rate during aggre-
gation.99 (b) Schematics of the electrical impedance measurement system.98 (c) A microﬂuidic device with a gold-plated electrode and an imped-
ance analyser.101 Reproduced from ref. 88, 94, 98, 99, and 101 with permission from the Royal Society of Chemistry, Public Library Science, IOS
Press, Elsevier Sci. Ltd, and IEEE – Institute of Electrical and Electronics Engineers.
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decreased depending on the shear rate. In addition, the
system can provide valuable information on rouleaux for-
mation or structural transformation of RBC aggregates during
the aggregation–disaggregation process.
Meiselman et al.98 compared RBC aggregations by analysing
the transmitted light intensity and electrical impedance
signals as shown in Fig. 8B-(b). Electrical impedance of 100
kHz and light transmittance were recorded under a high shear
flow and for 120 s after abrupt stoppage of blood flow, during
which RBC aggregation occurs. RBC aggregation was then
quantified from capacitance values obtained from electrical
impedance data. The RBC aggregation parameters derived
from capacitance data were in good agreement with those
obtained from light transmittance data.
Yang et al.101 established a microfluidic-based ESR
measurement method by monitoring temporal variations in
electrical impedance signals of blood with various haemato-
crits. As shown in Fig. 8B-(c), the microfluidic-based conduc-
tivity measurement system was composed of a PDMS chamber
with a square cross section (width = 5 mm and depth = 5 mm)
and two gold-deposited planar electrodes (thickness = 0.3 µm
and width = 300 µm) that were 1200 µm apart. After a blood
sample was dropped into the PDMS chamber, the electric con-
ductivity of the test blood was measured with an impedance
analyser. The measured blood conductivity increased for the
first 1 min and decreased thereafter. Theoretical analysis
revealed that the initial increase in blood conductivity was
caused by RBC aggregation, and the subsequent decrease
resulted from the deposition of RBCs. The ESR value obtained
from the electrical impedance signal showed a suﬃcient corre-
lation with the standard Westergren ESR method.
2.3.3 Microscopic image-based measurement of RBC
aggregation. Local RBC aggregation in micro-scale blood flows
or bifurcating microchannel flows is important because the
blood flow and haematocrit are not uniform. For this reason,
Balabani et al.102,103 investigated spatial distributions of RBC
aggregation in a T-shaped bifurcation. Fig. 9A shows a sche-
matic of the microfluidic system. A pressure control device was
employed to supply blood from the parent conduit (P) (width =
100 µm and depth = 40 µm) towards two daughter branches
(L and R). The velocity field and streamlines of RBC aggregation
at a flow rate of QD/QP = 0.13 are shown in the right panel of the
figure. QP and QD denote the flow rate of the parent and right
daughter conduits, respectively. The size of RBC aggregation was
determined by adopting an image processing technique. The
mean aggregated size was marginally increased in the daughter
branches mainly due to low shear rates. This result was attribu-
ted to the depletion of RBC aggregation in certain regions of the
parent conduit and to the change in the flow-split location in the
T-junction with respect to the flow rate ratio.
Lee et al.104 conducted a microfluidic-based speckle ana-
lysis for the sensitive measurement of RBC aggregation. As
shown in Fig. 9B, the microfluidic device had a single inlet, a
straight channel (width = 1 mm, depth = 50 µm and length =
10 mm) and a single outlet. After selecting a specific region of
interest (ROI) of 128 × 128 pixels, the normalized autocorrela-
tion function ( fauto) was calculated along the horizontal and
vertical directions. The size of the speckle pattern (SH and SV)
was estimated as the corresponding width at half of fauto ( fauto =
0.5). Then, the average speckle area (ASpeckle) was evaluated by
multiplying the horizontal and vertical speckles (i.e. ASpeckle =
SH·SV). As shown in the right figures, the speckle patterns
Table 3 Summary of microﬂuidic-based techniques for measuring RBC aggregation
Principle Measurement quantity Test cell Comment Ref.
Photometric method
(transmission, scattering)
Light intensity and shear
stress
RBC in fibrinogen suspension Scattered light (laser, photodiode) 93 and
94
Light transmission or
back scattering
Blood delivery with a vacuum pump
Light intensity and
microscopic image
RBC in dextran suspension RBC disaggregation with a pinch valve 88
Comparison of ESR and RBC
aggregation
Electrical conductivity Conductivity RBC in plasma Comparison of ESR and conductivity 99 and
101
Microscopic image Aggregation size Whole blood
(haematocrit = 25%)
Image processing 102 and
103Velocity field Partitioning of RBC aggregation in a
T-shaped bifurcation channelCell-depleted layer
Speckle size RBC in dextran suspension Single channel 104
Diabetic rat blood Comparison of ultrasonic, microscopic
image and ESR
Cluster size and
occurrence
RBC in dextran or fibrinogen
suspension
In vivo or in-vitro 105
Image intensity Malaria-infected blood
(haematocrit = 30%)
ESR measurement with a syringe pump 92
RBC in dextran suspension
RBC in dextran suspension Periodic on-oﬀ control of blood flow 34
Simultaneous measurement
RBC in dextran suspension Periodic delivery with a disposable
pump
61
RBC aggregation under continuous
sedimentation
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appeared over time. After the flow of blood (RBC suspended in
0.06% dextran solution, haematocrit = 40%) was stopped,
ASpeckle gradually increased. Through quantitative comparisons
with conventional measurement methods, including the con-
ventional ESR method, microscopic observation and ultra-
sound imaging, the speckle area (ASpeckle) can be used to evalu-
ate RBC aggregation eﬀectively.
Wagner et al.105 investigated the eﬀects of dextran and fibri-
nogen on RBC aggregation in micro-capillaries. Fig. 9C shows
a cluster of RBCs passing through a capillary vessel of a
mouse, a microfluidic device (N = 30, width = 8.5 µm and
depth = 4.5 µm) and the numerical simulation result on the
eﬀect of fibrinogen on two diﬀerent channel widths (w) (w =
4.5 and 12 µm). At high shear rates in the micro-capillaries or
low haematocrit of 1%, fibrinogen or dextran enhanced the
formation of robust clusters of RBCs. This persistent RBC
aggregation exerted an influence on the spatial distribution of
RBCs and blood perfusions in microvascular networks.
Lee et al.92 reported a microfluidic-based ESR measurement
technique to detect malaria-infected RBCs collected from a
mouse. As shown in Fig. 9D, a disposable syringe filled with
blood was turned upside down in the gravitational direction.
When blood was supplied to a microfluidic device from the
top of the syringe, the haematocrit of the blood decreased due
to continuous ESR in the syringe. By assuming the image
intensity of blood flow as I(t ) = α + β exp(−t/λESR), the dynamic
variation in ESR was evaluated with two parameters, namely,
the time constant (λESR) and ESR area (AESR). The two para-
meters varied significantly when RBCs were suspended in a
dextran solution (haematocrit = 30%). The ESR and viscosity of
malaria-infected RBCs increased significantly with respect to
the parasitemia level.
Kang61 proposed a microfluidic-based technique for
measuring RBC aggregation under haematocrit variation due
to continuous ESR in the tip of a conical pipette. As shown in
Fig. 9E, a conical pipette tip was tightly fitted into the inlet
Fig. 9 Microﬂuidic-based measurement of RBC aggregation by analysing microscopic images of aggregated RBCs in a microﬂuidic channel. (A)
Spatial distributions of RBC aggregations in T-shaped bifurcation.102 (B) Analysis of speckle patterns in a straight microﬂuidic channel.104 (C) Cluster
size and occurrence of RBCs in micro-capillary ﬂows.105 (D) Microﬂuidic-based ESR measurement using a disposable syringe by analysing the image
intensity of blood ﬂow in a microﬂuidic channel.92 (E) Variation in RBC aggregation owing to continuous ESR in a conical pipette tip under periodic
on–oﬀ blood delivery by using a disposable suction pump.61 Reproduced from ref. 61, 92, 102, 104, and 105 with permission from MDPI AG, AIP
Publishing, and Nature Publishing Group.
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port, and a disposable suction pump was connected to the
outlet. After dropping blood (∼0.2 mL) into the conical
pipette tip, blood flow was turned on and oﬀ by periodically
operating a pinch valve. To eﬀectively evaluate variations in
RBC aggregation due to continuous ESR, an erythrocyte sedi-
mentation rate aggregation index (EAI) was newly defined
from temporal variations in the image intensity of blood
flows in the microfluidic channel. EAI was more eﬀective
than the conventional AI in monitoring variations in RBC
aggregation due to continuous ESR. In addition, the EAI
gradually increased with the increase in the concentration of
the dextran solution.
Kang34 suggested a simple method for the continuous and
simultaneous measurement of biophysical properties of blood,
including viscosity, viscoelasticity and RBC aggregation. The
blood sample was precisely delivered into the inlet (A) under
pulsatile flow rate conditions. However, PBS solution was sup-
plied to the inlet (B) at a constant flow rate. By operating a
pinch valve connected to the outlet (A), blood flow was
stopped or allowed to pass through the lower left channel.
Then, the biophysical properties of blood were quantified by
analysing the flow rate in the upper left channel (QµPIV), image
intensity in the lower left channel (〈I〉Blood) and blood-filled
width in the lower right channel (αBlood). To consistently
measure RBC aggregation, the value of 〈I〉Blood was obtained
from the corresponding time of the minimal image intensity
(〈I〉0) for 100 s. RBC aggregation was then evaluated in terms
of the linear slope of the image intensity (〈I〉slope), the integral
of the image intensity above the minimal image intensity for
100 s (Aupp), the integral of the minimal image intensity for
100 s (Alow), and the ratio of Aupp to Alow (i.e., Aratio = Aupp/Alow).
Three parameters (〈I〉slope, Aratio and Aupp) defined from 〈I〉Blood
were varied significantly depending on RBC aggregation. The
addition of dextran solution increased blood viscosity and RBC
aggregation. However, a glutaraldehyde solution did not con-
tribute to varying RBC aggregation.
2.3.4 Discussion on RBC aggregation measurement tech-
niques. As summarised in Table 3, several RBC aggregation
measurement techniques, including photometric intensity,
electric conductivity, and microscopic images, have been used
to quantify RBC aggregation flowing in a microfluidic device.
By agitating RBCs with a disaggregation mechanism, RBC
aggregation was quantified by analysing light intensity, electric
conductivity and image intensity. Compared with measure-
ments of blood viscosity and RBC deformability, RBC aggrega-
tion has been widely adopted to detect various pathological
diseases in clinical settings. Using a microfluidic platform, the
eﬀects of plasma protein (i.e. fibrinogen) or dextran solution
on RBC aggregation were examined by monitoring the size of
clusters or the cell-depleted layer of RBCs in microfluidic chan-
nels or capillary networks.102,105 In addition, RBC aggregation
and ESR were simultaneously measured by analysing light
transmission intensity and microscopic images.88 Recently, a
new RBC aggregation index (EAI) was proposed to monitor
variations in RBC aggregation due to continuous ESR in reser-
voirs.61 However, because all methods were developed to
measure RBC aggregation under in vitro conditions, several
issues (blood collection, storage time, and hemodilution)
hinder measuring the RBC aggregation of real blood circulat-
ing in a closed ex vivo circuit. Thus, improving or modifying
these methods is required for the measurement of RBC aggre-
gation under ex vivo conditions.
3. Ex vivo blood physical analysis of
an animal model
To quantify various biophysical properties of blood circulating
in complex fluidic circuits, including hemodialysis106 and a car-
diopulmonary-bypass procedure,107,108 blood samples have
been collected from conduits. Then, the haemorheological
properties of the blood were measured under in vitro
conditions.
Whittaker et al.109 reported that blood viscosity measured
with an Oswald viscometer (in vitro conditions) is higher than
that estimated based on the pressure and flow rate curve for
the hind limb of a dog (in vivo conditions). This result is attrib-
uted to the much larger diameter of the Oswald viscometer
(inner diameter = 930 µm) compared with that of real blood
vessels. The Fahraeus–Lindqvist eﬀect,110 which depends on
vessel diameter owing to the cell-free layer,111,112 endothelial
glycocalyx113 and vasomotor control,114 contributes to the
diﬀerence in blood viscosities measured by in vivo and in vitro
experiments.43 Given the diﬀerent geometries between blood
vessels and in vitro instruments, in vitro methodology cannot
provide consistent rheological properties of blood compared
with in vivo measurement techniques, including electrical
impedance catheters,115,116 photo-acoustic and photo-thermal
cytometry,117 cellular ultrasound imaging method118 and
microscopic image-based velocimetry.119,120 In addition,
haemorheological properties are significantly varied due to the
presence of artefact (blood–air interface)121 and storage con-
ditions.122,123 During blood collection, haemodynamic pro-
perties, including flow rates or pressures in the closed
conduit, are not specified. For this reason, haemorheological
properties of blood have been measured over a wide range of
shear rates, rather than at a specific shear rate condition.
Considering that blood collections decrease the blood volume
in the closed loop, a lactated Ringer’s solution is applied to
maintain blood volume during cardiopulmonary bypass pro-
cedures.107 However, this hemodilution causes to vary the
haemorheological properties significantly. To minimise or
remove blood collection from the closed conduit, various
methods have been suggested to quantify the biophysical pro-
perties of real blood circulating under ex vivo conditions.124,125
The measurements of haemorheological properties under
in vivo and ex vivo conditions are summarized in Table 4.
3.1 Microfluidic-based haemorheological measurements
under ex vivo conditions
Lee et al.42–44,126–128 used an extracorporeal rat bypass loop to
study microvascular haemodynamics. As shown in Fig. 10A-(a),
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an extracorporeal rat bypass loop was constructed by connect-
ing a fluorinated ethylene propylene (FEP) tube from the
jugular vein to the femoral artery. Microscopic images of blood
circulating in the loop were sequentially captured with a high-
speed camera. The velocity profiles of blood flow in the bypass
FEP tube were obtained by conducting the time-resolved
micro-particle image velocimetry technique for microscopic
images of blood flows. As shown in Fig. 10A-(b), the centre ve-
locity in the bypass FEP tube can be controlled by adjusting
the main tube with a pinch valve. The ratio of the systolic
blood velocity to the diastolic blood velocity decreased with
increasing blood flow rate. The blood rate and amplitudes of
pulsatile blood flow can be easily controlled by adjusting the
pinch valves installed in the arteriovenous shunt loop.
Therefore, the proposed bypass loop had a strong potential for
obtaining haemodynamic information on real blood flows.
Given that previous in vitro experiments measured blood
viscosity under a specific flow rate, their methods are lacking
when used to evaluate blood viscosity at unspecified flow
rates. For this reason, a flow rate sensor is installed in the
closed fluidic circuit to measure the blood flow rate. However,
tedious cleaning or calibration is required after each experi-
mental measurement. To resolve this problem, a twin-shaped
microfluidic device was introduced in a previous study for the
simultaneous measurement of viscosity and flow rate of whole
blood circulating in a complex fluidic circuit that includes a
rat, a reservoir, a pinch valve and a peristaltic pump.42 As
shown in Fig. 10B-(a), rat blood was delivered to the blood
reservoir at an unknown flow rate (Qx) by adjusting the pinch
valve. The blood was supplied to the microfluidic device using
a peristaltic pump at a specific flow rate. The microfluidic
device was composed of two half-circular chambers (diameter =
22 mm and depth = 50 µm), two side channels with mul-
tiple microchannels (N = 25, width = 300 µm and depth =
50 µm) connected by a bridge channel. Firstly, by using rever-
sal flow switching manipulation in the bridge channel,15
blood viscosity was measured under two diﬀerent blood flow
rate conditions [(a) specified flow rate via a syringe pump and
(b) unspecified flow-rate via a peristaltic pump]. The blood
flow rate (QBlood) and blood viscosity (µBlood) were simul-
taneously measured with good measurement accuracy and
reliability. Then, the viscosity of rat blood flowing in the
complex fluidic network was measured. The number of chan-
nels filled with blood (NBlood) remained constant at NBlood =
18–19, as shown in Fig. 10B-(b), due to the compliance eﬀect
of the half-circular chamber. By using two distinctive relation-
ships (NBlood vs. QBlood, µBlood vs. QBlood) that were experi-
mentally obtained, the viscosity of rat blood was evaluated as
5.89 ± 0.08 cP at a flow rate of 3.8 mL h−1. Through experi-
mental demonstrations, the proposed method was found to
be a promising technique for eﬀectively evaluating the flow
rate and viscosity of whole blood circulating in a complex
fluid network without sensors and tedious labelling pro-
cedures. In addition, it will be employed to measure temporal
variations of blood viscosity during a cardiopulmonary bypass
procedure or haemodialysis.
To monitor temporal variations in the biophysical pro-
perties of rat blood, including viscosity, flow rate and pressure,
Table 4 Summary of haemorheological property measurement under in vivo and ex vivo conditions
Experimental
condition
Measurement
quantity Animal model Comment Ref.
In vivo RBC velocity Venule (rat) Eﬀect of RBC aggregation on velocity profile in
venule
120
Blood viscosity Right atrium (10
patients)
Electrical impedance technique with central venous
catheter
115 and
116
On-pump heart surgery
Blood velocity Nude mouse Photo-acoustic and photo-thermal flow cytometry 117
Haematocrit
RBC aggregation
Blood viscosity
RBC aggregation Diabetic patients Ultrasound imaging (aggregation size) 118
Flow rate
Blood velocity LPS-stimulated
zebrafish
Discrete circuit model 119
Wall shear stress
Ex vivo Velocity profile Rat Micro-PIV technique 126
Three pinch valves for controlling blood
flowPulsatility index
Blood viscosity Rat Microfluidic device 42 and 43
Flow rate Discrete circuit model
Pressure Periodic blood collection (required)
Blood viscosity Rat Hybrid system (microfluidic device and ultrasound
system)
44
Pressure
RBC aggregation Discrete circuit model
Velocity profile Periodic blood collection (required)
Image intensity Pig Shear gradient microfluidic
device
125
Pressure drop
Clotting time Monitoring whole blood hemostasis and platelet
function
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a complex fluidic circuit was established in a study by connect-
ing the abdominal aorta and jugular vein to an extracorporeal
bypass loop that includes a flow stabilizer59,60 and a
Wheatstone-bridge analogue microfluidic channel.15 Based on
two consecutive controls for reversal flow switching in the
bridge channel,15 blood viscosity and flow rate were simul-
taneously measured at a specific duration of time. In addition,
the pressure at the abdominal aorta was analytically estimated
using a discrete fluidic circuit model. As shown in Fig. 11A-(a),
the proposed method was employed to monitor temporal vari-
ations in the biophysical properties of rat blood circulating in
the fluidic network, especially under a continuous hemodilu-
tion condition. After 30 min elapsed, PBS solution was sup-
plied to the inlet (B) at a flow rate of 3 mL h−1. To monitor
reversal flow switching in the bridge channel,15 rat blood of
1 mL h−1 was repeatedly collected at intervals of 20 min from
the outlet (B) after the stoppage of the syringe pump for the
PBS solution. Given that the supplied volume of PBS solution
for 20 min (ΔVPBS = 1 mL) was equal to the collected rat blood
(ΔVBlood = 1 mL), the overall volume of rat blood was main-
tained at a constant level under a continuous hemodilution
condition (i.e. ΔVBlood = ΔVPBS = 1 mL for 20 min).
Haematocrit [Fig. 11A-(b)], balancing pressure [Fig. 11A-(c)]
and flow rate [Fig. 11A-(d)] gradually decreased due to the con-
tinuous hemodilution. The balancing pressure at the left junc-
tion (PX) in the microfluidic channel was estimated using a
discrete fluidic-circuit model. As shown in Fig. 11A-(c), the bal-
ancing pressure was decreased gradually with the elapse of
time. In addition, the blood pressure in the abdominal aorta
(Prat) was decreased due to a continuous hemodilution eﬀect.
The reduced flow rate contributed to increased blood viscosity
[Fig. 11A-(e)]. The proposed method was applied to monitor
variations in biophysical properties and platelet aggregation
depending on the diabetic duration after streptozotocin treat-
ment in a rat.127 After collecting blood from the ex vivo bypass
loop, RBC aggregation was quantified through a modified ESR
method.92,104 The haemorheological properties of the diabetic
rat blood were significantly changed compared with those in a
normal rat. Platelet adhesion was considerably increased with
the increase in diabetic duration. In addition, the proposed
Fig. 10 Microﬂuidic-based measurements of haemorheological properties under ex vivo conditions. (A) Extracorporeal rat bypass loop for hemo-
dynamic analysis.126 (a) Schematic of an experimental setup including an extracorporeal bypass ﬂuidic conduit, three pinch valves and a microscopic
image acquisition system. (b) Variations in centreline velocity and velocity proﬁles at systolic and diastolic phases. (B) Simultaneous measurement of
viscosity and ﬂow rate of blood ﬂow in a complex ﬂuidic circuit.42 (a) Schematic of an experimental setup including a rat, a pinch valve, a reservoir, a
microﬂuidic device, a peristaltic pump and a syringe pump. (b) Temporal variation in the number of indicating channels ﬁlled with blood in the right-
side channel. The inset shows two distinctive relationships (i.e. NBlood vs. QBlood and wBlood vs. QBlood). Reproduced from ref. 42 and 126 with per-
mission from Academic Press Inc. and American Institute of Physics.
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method was successfully employed to monitor variations in
the biophysical properties of a sepsis rat model established by
injection of lipopolysaccharide.128
An ultrasound imaging system was additionally employed
to monitor RBC aggregation in a rat bypass loop because high
shear rates in the microfluidic channel hinder the quantifi-
cation of RBC aggregation occurring at stasis.44 As shown in
Fig. 11B-(a), the extracorporeal ray bypass loop was constructed
by connecting a rat, a pulse-free chamber (or fluidic stabil-
izer59,60), a twin-shaped microfluidic device,15 a syringe pump
Fig. 11 Microﬂuidic-based measurements of haemorheological properties under ex vivo conditions. (A) Temporal variations in the biophysical pro-
perties (viscosity, ﬂow rate and pressure) of rat blood circulating through a complex ﬂuidic network under continuous hemodilution.43 (a) Schematic
of the experimental setup. (b) Temporal variations in switching ﬂow rate of PBS (QsPBS) and haematocrit of blood (Hct). (c) Temporal variations in
blood pressure at the abdominal aorta (P). (d) Temporal variations in ﬂow rate (QRat) and blood viscosity (μRat). (e) Variations in blood viscosity with
respect to ﬂow rate at a speciﬁc time of t = 130 min. (B) Hybrid system used for haemorheological and hemodynamic analysis composed of a
microﬂuidic platform and an ultrasonic imaging system.44 (a) Schematic of the experimental setup. (b) Temporal variations in switching ﬂow rate
(QsPBS) and blood ﬂow rate (QBlood). (c) Temporal variations in temperature (T ) and heart rate (HR). (d) Temporal variations in blood viscosity (μ) and
pressure at the abdominal aorta (P). (e) Temporal variations in echogenicity (E) and decorrelation (Ds). Reproduced from ref. 43 and 44 with per-
mission from the American Chemical Society and Nature Publishing Group.
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and an ultrasonic imaging system. The biophysical properties
of rat blood were measured at intervals of 20 min for 100 min.
As shown in the experimental results [Fig. 11B-(b)–(e)], after
injecting a specific concentration of dextran solution at
50 min, the echogenicity (E) measured by the ultrasonic
system and the blood viscosity (µ) measured by the micro-
fluidic device increased over time due to the enhanced RBC
aggregation by the dextran solution. In addition, the mean
pressure at the abdominal aorta and flow rate gradually
decreased. Experimental demonstration showed that the
hybrid system can be eﬀectively used to measure temporal vari-
ations in biophysical properties, including RBC aggregation,
viscosity, flow rate and blood pressure.
3.2 Blood clotting and cell activation
Under ex vivo circulation, a polyethylene tube was used to
connect the microfluidic device with blood vessels. The inner
surfaces of tubes and microfluidic channels are made to come
into direct contact with blood cells. Blood cells adhered on the
inner surface of the tubes or microfluidic channels because
blood cells are in contact with the non-physiological surface,
and this phenomenon could cause interruption in blood flows.
When platelets were exposed to high shear stress, they adhered
and aggregated to the surface, which hindered blood flows.127
The hydrophobic surface properties of silicon-based
materials can induce adsorption of plasma proteins, and acti-
vate blood clotting sequentially.129 Due to blood clotting in
microfluidic channels or tubes, the functionality of the micro-
fluidic device decreased over time.59,130,131 By modifying the
surface properties of silicone-based materials with PMC poly-
mers, unfavourable protein adsorptions were significantly
reduced, compared with uncoated surfaces.129,132 Since it is
diﬃcult to recreate the endothelium in microfluidic channels,
a nitric oxide donor or soluble thrombomodulin was added to
replace the endothelium.133 The non-physiological contact
surface could be reduced or eliminated by adopting elasto-
meric blood vessels134,135 or implanted microfluidic devices.136,137
High shear stress and direct contact with sub-endothelial
collagen also contribute to activating platelets, and formulat-
ing thrombus in microfluidic channels.130,138 When platelets
exposed to high shear stress for a short time were irreversibly
activated and aggregated at high shear stress, blood flow
was stopped in a microfluidic channel. Thus, platelet aggre-
gation was measured by monitoring the migration distance
until the blood flow was completely stopped.138 Platelet aggre-
gation usually causes to decrease blood flow until it reaches
occlusion time. The unstable thrombus detachment increased
blood flow suddenly.131 When blood viscosity was measured
by monitoring the interfacial line between two co-flowing
streams, platelets were activated and stacked in the interfacial
line or surface of the channel. Thus, blood viscosity was inac-
curately measured, and continuously varied over time.59,130
Several microfluidic devices were introduced to measure
coagulation or clotting of blood. Ingber et al.125 suggested a
shear gradient-activated microfluidic device for automatic
monitoring of platelet function and thrombus formation.
Using a microfluidic device mimicked from a network of
stenosed arteriolar vessels, blood clotting was evaluated with a
small volume of blood under pathophysiological flow con-
ditions. By analyzing clotting time with a mathematical model
of thrombus formation, the coagulation and platelet functions
could be accurately evaluated through in vitro and ex vivo
experiments. Maddala et al.139 suggested a multi-bypass micro-
fluidics ladder network mimicked from venules to study plate-
let aggregation and fibrin formation under blood flows.
Dynamic blood flow was used to predict the patterns of blood
clotting at specific locations in the device. This method pro-
vided a correlation between microvascular geometry and
thrombus formation under blood flow. Lee et al.130 suggested
a correlation mapping for estimating platelet adhesion in a
microfluidic channel. The platelet adhesion was evaluated by
integrating the area of adhered platelets (Aplatelet) for a specific
time. Under ex vivo conditions, they measured platelet
adhesion and blood viscosity simultaneously over time.
Through a comparative study, the blood viscosity and platelet
adhesion of diabetic rats were found to be higher than those
of normal rats.
For point-of-care testing, a miniaturized clot device was
developed to measure the dynamic clot refraction forces using
a small volume of whole blood.140 In addition, a microfluidic
dielectric sensor was introduced to measure multiple coagu-
lation factors and platelet activity.141
3.3 Discussion on a haemorheological study under ex vivo
conditions
Most previously developed techniques43,44 still present techni-
cal limitations in continuous measurements of biophysical
properties of blood. Firstly, after collecting blood samples
from the closed loop repeatedly, blood viscosity or RBC aggre-
gation was measured under in vitro conditions. Given that
blood volume circulating in the closed loop decreased gradu-
ally, the total monitoring time was relatively short (less than
100–120 min). In addition, haemorheological properties,
including viscosity and RBC aggregation, were repeatedly
monitored at specific intervals of time instead of a continuous
mode. To resolve these problems, haemorheological properties
in closed-loop circulation must be measured without the col-
lection of blood from the closed loop. Secondly, conventional
methods utilise bulk-sized instruments, such as a microscope
equipped with a high-speed camera for measuring fluid ve-
locity or an ultrasonic imaging system for measuring RBC
aggregation. Thus, they can be used only in laboratory environ-
ments equipped with expensive instruments. Evidently, detect-
ing haemorheological properties with simple analytical
sensors, including pressure sensors, flow rate sensors,
vibrational spectroscopes and impedance analysers, is
required. Lastly, previous methods focused on two haemorheo-
logical properties, namely, blood viscosity and RBC aggrega-
tion. Although RBC deformability or haematocrit is considered
an eﬀective parameter for detecting cardiovascular diseases,
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previous methods did not provide information on RBC
deformability under ex vivo conditions. Thus, multiple haemo-
rheological properties, including blood viscosity, RBC aggre-
gation and RBC deformability, need to be measured under
ex vivo conditions.
4. Conclusions and perspectives
Biophysical properties of blood, including blood viscosity, RBC
aggregation and RBC deformability, have been independently
measured to monitor their variations in blood specimens col-
lected from patients with haematological disorders. In this
review, several techniques for measuring haemorheological
properties (blood viscosity, RBC deformability and RBC aggre-
gation) based on microfluidic platforms (i.e. in vitro condition)
and extracorporeal bypass loops of animal models (i.e. ex vivo
condition) were discussed. New technologies that can eﬀec-
tively and consistently provide comprehensive information on
biophysical properties of blood circulating in the ex vivo closed
loop are still needed. Firstly, commercialized products for the
clinical measurement of haemorheological properties were
summarized in Fig. S1 (ESI†). Most techniques were focused
on a single property rather than multiple properties. An
eﬀective haemorheological index combined with several bio-
physical properties has not been proposed to diagnose
haematological diseases under in vitro conditions. Thus, a
blood-on-a-chip scheme needs to be developed for simul-
taneous measurements of haemorheological properties from a
blood sample with a small volume. Secondly, most previous
techniques are feasible under in vitro experimental conditions
only. They require bulk-sized instruments, including a micro-
scope for visualising blood flows and a high-speed camera for
observing flow images. In addition, when an in vitro method is
employed to measure haemorheological properties under
ex vivo conditions, initial hemodilution is basically required to
collect blood, and blood viscosity is then measured under
in vitro conditions. However, hemodilution can alter the bio-
physical properties of blood measured for a short-term period
of 100–130 min. To resolve these problems, a new analytical
method should be developed for long-term and continuous
measurements of haemorheological properties without hemo-
dilution and periodic blood collection. Lastly, long polyethyl-
ene tubes are usually employed to connect a microfluidic
device with blood vessels for establishing the extracorporeal
rat bypass loop. Given that blood cells are in direct contact
with a non-physiological surface, they adhere on the inner
surface of the tube, which interrupts blood flows in a short-
term period. To resolve this problem, the non-physiological
surface must be reduced or removed by using elastomeric
blood vessels134,135 or implanted microfluidic devices.136,137 In
the near future, a new analytical methodology based on a
microfluidic platform will be employed to diagnose haemato-
logical disorders and to screen eﬀective treatment methods for
curing them.
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